Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.
Clinical trial NCT05421104 · COMPLETED
Trial details
- NCT number
- NCT05421104
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-06-29
- Enrollment
- 1576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.